Search Results

Business

AIVITA Biomedical Strengthens Board of Directors with Appointment of Ex-Biogen CEO Michel Vounatsos

AIVITA Biomedical, Inc. today announced the appointment of distinguished healthcare executive Michel Vounatsos to its board of directors.

February 27, 2024

·

3 min read

Biotech Beach

AIVITA Biomedical CEO Dr. Hans Keirstead to Join Keynote Panel for AI in Public Health at World Vaccine Congress

AIVITA Biomedical, Inc., a biotech company specializing in innovative stem cell applications, announced that chief executive officer Hans S. Keirstead, Ph.D. will participate in a keynote panel at the World Vaccine Congress taking place April 1-4 in Washington, D.C.

April 2, 2024

·

2 min read

Biotech Beach

AIVITA Biomedical CEO Dr. Hans Keirstead and CMO Dr. Robert Dillman to Speak and Participate in Keynote Panel at Festival of Biologics USA

AIVITA Biomedical, Inc. today announced that chief executive officer Hans Keirstead , Ph.D. and chief medical officer Robert Dillman , M.D. will speak and participate in a keynote panel at the Festival of Biologics USA , taking place April 15-19 in San Diego, California.

April 11, 2024

·

2 min read

Biotech Beach

AIVITA Biomedical CEO Dr. Hans Keirstead to Present at Biotech Showcase 2024

AIVITA Biomedical, Inc. today announced that chief executive officer Hans S. Keirstead, Ph.D. will present at Biotech Showcase 2024, taking place January 8-10 in San Francisco, California.

January 5, 2024

·

2 min read

Biotech Beach

AIVITA Biomedical CEO Dr. Hans Keirstead to Deliver Keynote at Advanced Therapies Europe

AIVITA Biomedical, Inc. today announced that chief executive officer Hans S. Keirstead, Ph.D. will participate in a keynote panel at Advanced Therapies Europe, taking place September 5-7 in Estoril, Portugal.

September 5, 2023

·

3 min read

Biotech Beach

AIVITA Biomedical Announces Case Report Suggesting Positive Collateral Benefits in Systemic Lupus Erythematosus Achieved Through the Use of Its Dendritic Cell Vaccine Kit

AIVITA Biomedical, Inc. announced the publication of a case report and literature review by distribution partners commercially deploying AIVITA’s Vaccine Kit, describing collateral benefits in a patient with systemic lupus erythematosus following vaccination using AIVITA’s anti-SARS-CoV-2 vaccine kit.

September 21, 2023

·

3 min read

Biotech Beach

AIVITA Biomedical CEO Dr. Hans Keirstead to Moderate Keynote Panel of Pharma Industry Leaders at World Vaccine Congress EU

AIVITA Biomedical, Inc. announced that chief executive officer Hans S. Keirstead, Ph.D. will moderate a keynote panel and deliver a talk at the World Vaccine Congress Europe, taking place October 16-19 in Barcelona, Spain.

October 13, 2023

·

2 min read

Biotech Beach

AIVITA Biomedical CEO Dr. Hans Keirstead to Participate in Keynote Panel and Deliver Talk at Festival of Biologics Europe

AIVITA Biomedical, Inc., a biotech company specializing in innovative stem cell applications, today announced that chief executive officer Hans S. Keirstead, Ph.D. will participate in a keynote panel and deliver a talk at the Festival of Biologics Europe, taking place October 10-12 in Basel, Switzerland.

October 9, 2023

·

2 min read

Biotech Beach

AIVITA Biomedical CEO Dr. Hans Keirstead to Deliver Keynote on AI in Healthcare at McKenna Institute Digital Innovation Summit

AIVITA Biomedical, Inc., a biotech company specializing in innovative stem cell applications, announced that chairman and CEO Dr. Hans Keirstead will deliver a keynote at the Digital Innovation Summit, taking place June 12-13 in St. Andrews, New Brunswick, Canada.

June 12, 2023

·

2 min read

Biotech Beach

AIVITA Biomedical CEO Dr. Hans Keirstead to Chair Keynote Panel and Present at World Vaccine Congress

AIVITA Biomedical, Inc., a biotech company specializing in innovative stem cell applications, today announced that chief executive officer Hans S. Keirstead, Ph.D. will chair a keynote panel and talk at the World Vaccine Congress taking place April 3-6 in Washington, D.C.

April 4, 2023

·

3 min read